Belles of the Ball: 2022 Triangle Heart Ball Illuminates Women’s Heart Health

white hearth-shape contour on the red background
By Karen Hill, Senior Vice President, Cardiovascular and Metabolics,

It was exciting to see so many people gathered to celebrate the American Heart Association’s (AHA) Triangle Heart Ball. After virtual meetings the past few years, the Raleigh Convention Center’s beautiful, vibrant ballroom sparkled with food, fun, and amazingly generous supporters united in a shared purpose to improve cardiovascular health. As the SVP of the cardiovascular therapeutic area for Worldwide Clinical Trials, I attended at the invitation of Peter Benton, the 2022 Triangle Heart Ball Chair and Worldwide’s president and Co-CEO. The event raised more than $900,000 to fund research, educational programs, and community initiatives designed to improve access to heart-healthy resources. This year’s theme — women’s health — was a personal one for Peter. He entertained us with stories of how he kept turning up at AHA meetings typically attended only by women. His presence was unusual enough to be noticed, so he was asked about his interest. He explained what we at Worldwide already know well: he is passionate about ensuring that all women, including his daughters and woman friends, are heard, and represented in healthcare, business, and other aspects of life. Peter and the AHA both recognize the importance of driving equitable health impacts, especially when it comes to heart health. Cardiovascular disease is the leading cause of death for people in the United States and globally....

Read More

Clinical Trials Raise Excitement Ahead of American College of Cardiology 2018 Conference

American College of Cardiology annual meeting
By Toni Bransford, MD, FACC, FASE, Executive Medical Director, Scientific Solutions, Cardiovascular and Metabolic Division, Worldwide Clinical Trials,

  The American College of Cardiology (ACC) annual meeting always promises to be an exciting conference for cardiologists and clinical investigators, particularly because it showcases new and innovative clinical technologies or novel uses of time-worn pharmaceuticals. Taking place March 10-12, this year’s meeting will be no exception. I will be there along with Worldwide’s Nancy Newark, RN, Executive Director of Cardiovascular Project Management, and Karen Hill, Senior Vice President, Global Therapeutic Leader, Cardiometabolic. Read on to learn about the sessions we plan to attend. If you’ll also be at ACC, I would love to connect while you’re in town! Please click here to drop me a note.

Read More

Equity in Cardiovascular Health: Charting the Course for Better Cardiovascular Health in African-American Communities

Cardiovascular Health in African-Americans
By Toni Bransford, MD, FACC, FASE, Executive Medical Director, Scientific Solutions, Cardiovascular and Metabolic Division, Worldwide Clinical Trials,

  In the spirit of Heart Month and Black History Month, which both occur in February in the United States, I was asked to take on the difficult question of equity in cardiovascular health in the African American community. But how does cardiovascular health relate to equity? To look at this, we have to look at equity in health and how it affects heart disease.

Read More

New Hypertension Guidelines: What’s Next for Hypertension Therapy?

Hypertension Guidelines, Cardiovascular Clinical Trial
By Toni Bransford, MD, FACC Executive Medical Director, Scientific Solutions, Cardiovascular and Metabolic Division, Worldwide Clinical Trials and Karen Modesto, MD, Senior Medical Director, Medical and Scientific Affairs, Cardiovascular and Metabolic Division, Worldwide Clinical Trials,

  Heart disease is the No. 1 cause of death in the world and the leading cause of death in the United States, killing about 610,000 people every year–that’s 1 in every 4 deaths, claiming more lives than all forms of cancer combined1, 2. Having high blood pressure puts you at risk for heart disease and stroke, which are leading causes of death. About 75 million American adults (32%) have high blood pressure—that’s 1 in every 3 adults and high blood pressure was a primary or contributing cause of death for more than 410,000 Americans in 2014—that’s more than 1,100 deaths each day1, 3.

Read More

Successfully Mitigating Costs in Large Cardiovascular Outcome Trials

cost mitigation strategies in cardiovascular studies
By Karen Hill, Senior Vice President, Project Management, Cardiometabolic, Worldwide Clinical Trials,

  The rising costs of clinical trials are especially pronounced in large cardiovascular outcome trials (CVOTs) due to the number of patients, investigators, clinical sites, and countries involved. However, there have been several successful attempts by Worldwide Clinical Trials, in partnership with sponsors and others, to mitigate these costs in recent years. Following is a summary of a few cost mitigation strategies employed in CVOTs.

Read More

5 Tips for Developing Lifestyle Modification Programs in Cardiovascular Outcome Trials

Cardiovascular study, lifestyle modification program
By Nancy Newark, BSN, RN, Executive Director, Project Management, Cardiometabolic & Late Phase, Worldwide Clinical Trials,

  In recent years an increasing number of cardiovascular outcome trials have been completed in patients with diabetes and obesity with high cardiovascular risk. In one of these studies, Worldwide Clinical Trials supported the development of a lifestyle modification program in partnership with the sponsor. Designed to encourage diet and exercise, this program included a survey of study participants to evaluate its impact. The survey results revealed that engagement in the program was lower than anticipated. However, there are several lessons learned that can be applied to similar healthy lifestyle initiatives in cardiovascular outcome trials.

Read More

Go Red: Know Your Numbers

heart on the sun
By Toni Bransford, M.D., FACC Executive Medical Director, Scientific Solutions, Cardiovascular and Metabolic Division, Worldwide Clinical Trials and Karen Modesto, MD, Senior Medical Director, Medical and Scientific Affairs, Cardiovascular and Metabolic Division, Worldwide Clinical Trials,

  This week begins Heart Month; a special time of year, used to shine a light on women’s risk of heart disease. Go Red Day occurs this Friday, February 2nd; Worldwide Clinical Trials will celebrate Go Red Day February 9th.

Read More